PROSTATE cancer is one of the most common cancers affecting men, and early, accurate diagnosis remains crucial to successful ...

Multiparametric MRI of the prostate has become diagnostic standard for evaluation of prostate lesions 1,2. The combination of T2-weighted images with diffusion-weighted imaging (DWI) and dynamic ...

O’Toole et al. have identified in this systematic review and meta-analysis manuscript [1] that MRI-based risk calculators significantly improved the discriminative ability to diagnose clinically ...

Removing one step from a three-part MRI scan, which could make them quicker, cheaper, and more accessible, had no negative impact on diagnostic accuracy, according to clinical trial results led by UCL ...

About The Study: In men with suspected prostate cancer, provided image quality is adequate, an abbreviated biparametric magnetic resonance imaging (MRI) scan, with or without targeted biopsy, could ...

Biparametric MRI, which omits the dynamic contrast enhancement sequence, can detect clinically significant prostate cancer as well as multiparametric MRI. Biparametric MRI performs as well as ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30–40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

A deep learning model was as effective as radiologists in detecting clinically significant prostate cancer on multiparametric MRI, a retrospective study suggested. In an internal test set of 400 ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

AI-driven MRI analysis offers new insights into prostate cancer prognosis, accurately predicting metastasis risk and treatment outcomes for improved patient care. Study: AI-derived Tumor Volume from ...

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...